Together, these findings further suggest that impaired glymphatic function, through decreased AQP4 expression, is capable of aggravating PD-like pathology in the brain, warranting further investigation of this pathway, or at least this water channel, as a therapeutic target in α-synucleinopathies. Here, AQP4 is linked to Parkinson disease.